Core Points - The company announced a cash dividend distribution of RMB 5.00 per 10 shares (including tax) to all shareholders, based on a total share capital of 200,732,618 shares after excluding repurchased shares [1][2] - The total cash dividend amount is calculated to be RMB 100,366,309, which translates to approximately RMB 0.4981 per share [1][2] - The record date for the dividend distribution is set for May 22, 2025, and the ex-dividend date is May 23, 2025 [3] Dividend Distribution Details - The dividend distribution plan was approved at the annual general meeting held on May 13, 2025, with a total share capital of 201,512,100 shares, of which 779,482 shares are held in the company's repurchase account and do not participate in the distribution [2] - The cash dividend will be directly credited to shareholders' accounts through their custodial securities companies on the ex-dividend date [3][4] - Different tax rates apply for various categories of shareholders, with specific provisions for Hong Kong investors and domestic investors holding different types of shares [2][4] Shareholder Commitments - The company has commitments from certain shareholders regarding the minimum selling price of their shares, which will be adjusted based on the dividend distribution [4] - The initial public offering price was RMB 26.91 per share, and this price will be adjusted to RMB 16.59 per share following the current dividend distribution [4]

证券代码：301101 证券简称：明月镜片 公告编号：2025-016 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 特别提示： 1、明月镜片股份有限公司（以下简称"公司"）通过回购专户持有的公司 股份 779,482 股，不参与本次权益分派。因此，本次权益分派以总股本扣除公司 回购专户中已回购股份后的总股本 200,732,618 股为基数，向全体股东每 10 股 派发现金股利人民币 5.00 元（含税）。 2、本次权益分派实施后，按公司总股本折算每股现金分红比例计算如下： 本次实际现金分红总额=（股权登记日的总股本-回购专户中的股份）×每股 分红金额=200,732,618×5÷10=100,366,309 元； 公司总股本折算每股现金红利=本次实际现金分红总额÷股权登记日的总股 本=100,366,309÷201,512,100=0.4980659 元/股，每 10 股现金红利为 4.980659 元； 3、2024 年度权益分派实施后的除权（息）价按照上述原则和方式执行，即 本次权益分派实施后的除权（息）参考价：除权（息）参考价格=（股权登记日 收盘 ...

Investment Rating - The investment rating for the light industry manufacturing sector is "Positive" [2] Core Insights - Overall consumer demand remains weak, but there are opportunities in specific segments where product and channel transformations can enhance market share, and brand recognition or performance recovery is expected [8] - The pet food segment shows high potential with strong consumer education barriers, brand loyalty, and significant single product effects [8] - The baby care market is fragmented, with strong brands rapidly increasing market share through cost-effectiveness and popular products, heavily relying on online sales [8] - Domestic second-tier brands in sanitary napkins and toothpaste are gaining market share, utilizing platforms like Douyin for marketing and channel empowerment [8] - The trend of innovative products and brand rejuvenation in the trendy toy sector is accelerating, with companies like Pop Mart and Blokus experiencing rapid revenue growth [8] Summary by Sections 1) Product & Channel Transformation - Baiya Co. reported a significant increase in revenue and is expected to see a gradual improvement in its profitability model [9] - Dengkang Oral Care's revenue growth exceeded expectations, with a sustainable improvement in profitability [9] - Runben Co. experienced strong revenue growth driven by new product launches, particularly in the sunscreen category [9] - Zhongchong Co. is successfully transforming its brand, with expectations of over 40% growth in its flagship product [9] - Companies in the trendy toy sector are well-positioned to benefit from consumer trends and new product launches [9] 2) High Competitive Barriers - Guibao Pet's revenue and profit growth exceeded expectations, driven by strong brand performance and successful high-end product launches [10] - The overall industry remains vibrant, with companies optimizing their product and channel structures [10] 3) Performance Recovery Expected - Chenguang Co. has underperformed due to a weak consumer environment, but recovery is anticipated if market conditions improve [10] - The company is focusing on enhancing its IP product strategy, which is expected to contribute to new growth points [10]

Investment Rating - The investment rating for the light industry manufacturing sector is "Positive" [2] Core Insights - Overall consumer demand remains weak, but there are opportunities in specific segments where product and channel transformations can enhance market share, and brand recognition or performance recovery is expected [2][8] - The pet food sector shows high potential with strong consumer education barriers, brand loyalty, and significant single product effects [2][8] - The baby care market is fragmented, with leading brands rapidly increasing market share through cost-effectiveness and popular products, heavily relying on online sales [2][8] - Domestic second-tier brands in sanitary napkins and toothpaste are gaining market share, utilizing platforms like Douyin for traffic generation and empowering other platforms and offline markets [2][8] - The trend of innovative products and brand rejuvenation in the trendy toy sector is accelerating, with companies like Pop Mart and Blokus experiencing rapid revenue growth [2][8] Summary by Sections 1) Product & Channel Transformation - Baiya Co. reported a significant revenue increase of 39% in Q4 2024 and 30% in Q1 2025, with a strong performance in e-commerce and a positive outlook for its probiotic series [3][9] - Dengkang Oral Care also showed robust growth, with a 39% increase in Q4 2024 and 19% in Q1 2025, benefiting from an optimized product structure and strong online sales [3][9] - Runben Co. experienced a 34% revenue increase in Q4 2024 and 44% in Q1 2025, driven by the rapid launch of new products [4][9] - The trendy toy sector, represented by companies like Blokus and Pop Mart, saw revenue growth of 156% and 278% respectively, indicating a strong market presence [4][9] 2) High Competitive Barriers - Guibao Pet's revenue and profit exceeded expectations, driven by strong growth in its proprietary brand and successful high-end product launches [10] - The overall industry remains buoyant, with companies optimizing product and channel structures, leading to sustained revenue growth and improved profitability [10] 3) Performance Recovery Expected - Chenguang Co. reported lower-than-expected performance due to a weak consumer environment, but recovery is anticipated if market conditions improve [10] - The company is focusing on enhancing its IP product strategy, which is expected to contribute to new growth points [10]

Core Viewpoint - The company reported a mixed performance in 2024, with a notable increase in revenue from its key products despite challenges in overseas business and raw material procurement [2][8]. Financial Performance - The total revenue for 2024 was 770 million yuan, representing a year-on-year growth of 2.88% [8]. - The net profit attributable to shareholders was 177 million yuan, showing a year-on-year increase of 12.21% [8]. - The gross profit margin reached 58.56%, an increase of 0.98 percentage points compared to the previous year [8]. Product Performance - The lens business revenue grew by 8.72% compared to 2023, indicating the effectiveness of the focus on major products [2]. - The PMC Ultra Bright series saw a significant revenue increase of 45.6% year-on-year, with growth trends continuing into Q1 2025 [2][11]. - The "Easy Control" series generated sales of 50.13 million yuan in Q1 2025, reflecting a year-on-year growth of 22.1% [9]. Market Strategy - The company has permanently exited the price war and shifted focus to high-end product development and brand building since 2019 [8]. - The company aims to expand its brand presence internationally, particularly in markets like Japan, Southeast Asia, and parts of Europe [12]. Industry Trends - The market for defocus lenses is experiencing rapid growth, with many companies entering this segment [9]. - Despite price wars initiated by some foreign brands, the negative impact is gradually diminishing [9]. Sales Channels - The sales strategy includes a mix of direct sales and distribution through 66 partners, including medical channels [11]. - The company has only one model experience store to assist clients in improving transaction efficiency rather than competing with them [11].

上海市广发律师事务所 关于明月镜片股份有限公司 2024 年年度股东大会的 法律意见书 电话：021-58358013 | 传真：021-58358012 网址：http://www.gffirm.com | 电子信箱：gf@gffirm.com 办公地址：上海市浦东新区南泉北路 429 号泰康大厦 26 楼 | 邮政编码：200120 上海市广发律师事务所 关于明月镜片股份有限公司 明月镜片股份有限公司（以下简称"公司"）2024 年年度股东大会于 2025 年 5 月 13 日在上海市普陀区岚皋路 567 号 3 楼会议室召开。上海市广发律师事务 所经公司聘请，委派成赟律师、陈雨兰律师出席现场会议，根据《中华人民共和 国公司法》（以下简称"《公司法》"）、《上市公司股东会规则》（以下简称"《股东 会规则》"）等法律法规、其他规范性文件以及《明月镜片股份有限公司章程》（以 下简称"《公司章程》"）的规定，就本次股东大会的召集和召开程序、召集人及 出席会议人员的资格、会议议案、表决方式和表决程序、表决结果和会议决议等 出具本法律意见书。 为出具本法律意见书，本所律师对本次股东大会所涉及的有关事项进行了审 查， ...

证券代码：301101 证券简称：明月镜片 公告编号：2025-014 明月镜片股份有限公司 2024 年年度股东大会决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 特别提示 一、 会议召开情况 6、 本次会议的召集、召开符合有关法律、行政法规、部门规章、规范性文 件和公司章程等的规定。 二、 会议出席情况 （一）股东出席的总体情况 出席本次股东大会现场会议和网络投票表决的股东及股东代理人共 141 人， 1、 本次股东大会不存在否决议案的情形。 2、 本次股东大会不涉及变更以往股东大会已通过的决议。 1、 召开时间： （1） 会议召开时间：2025 年 5 月 13 日（星期二）14:30。 （2） 网络投票时间：2025 年 5 月 13 日。 其中通过深圳证券交易所交易系统进行网络投票的具体时间为：2025 年 5 月 13 日 9:15—9:25，9:30—11:30 和 13:00—15:00；互联网投 票系统投票的时间为 2025 年 5 月 13 日 9:15—15:00 期间的任意时 间。 2、 召开地点：上海市普陀区岚皋路 567 ...

Group 1 - The article by Mayor Ma Minglong has significantly boosted the confidence of enterprises in the Danyang eyewear industry [1] - Danyang Eyewear Chamber of Commerce calls for government policies focusing on technological breakthroughs, brand internationalization, and ecological integration to position Danyang as a "world eyewear innovation source" [2] - The Danyang eyewear industry is transitioning from "scale expansion" to "quality improvement," necessitating precise policy support for high-end talent recruitment and R&D funding [2] Group 2 - The Danyang eyewear market needs to enhance its core competitiveness through industry standards, employee training, and market management [3] - There is a need to improve professional requirements and technical quality standards in the eyewear industry, particularly in the fitting process [3] - Employee training is crucial for ensuring the quality of eyewear fittings, emphasizing the importance of thorough checks and trials of finished products [3]

Group 1: Financial Performance - In 2024, the company achieved total revenue of 770 million yuan, a year-on-year increase of 2.88% [1] - The gross profit margin was 58.56%, up 0.98 percentage points from the same period last year, with a net profit attributable to shareholders of 177 million yuan, an increase of 12.21% year-on-year [1] - For Q1 2025, the company reported total revenue of 197 million yuan, a year-on-year increase of 2.63%, and a net profit of 47 million yuan, up 11.70% year-on-year [1] Group 2: Product Performance - The lens business grew by 8.72% year-on-year after excluding the negative impacts of overseas and raw material businesses, with star products performing exceptionally well [1] - The PMC Ultra Bright series saw revenue growth of nearly 45.6%, with three star products accounting for 54.6% of total revenue from regular lenses [1] - The "Easy Control" product line maintained rapid growth, with Q4 2024 sales reaching 41.58 million yuan, a year-on-year increase of 23.6%, and total sales for the year at 163.65 million yuan, up 22.7% [1] Group 3: Strategic Partnerships and Market Position - In April 2024, the company announced an exclusive partnership with Leica, focusing on high-end lens markets in China [2] - The company primarily operates in the domestic market with a direct sales model complemented by distribution, optimizing its customer structure [2] - By the end of 2024, the company had 2,707 direct sales customers and 66 distribution customers, including medical channels [2] Group 4: Future Projections - Revenue projections for 2025-2027 are 859 million, 951 million, and 1.05 billion yuan, with year-on-year growth rates of 11.5%, 10.7%, and 10.4% respectively [2] - Net profit projections for the same period are 199 million, 227 million, and 257 million yuan, with growth rates of 12.5%, 14.2%, and 13.3% respectively [2]

Group 1 - The A-share AI glasses sector is experiencing active trading, with significant price movements observed in several companies [1] - Yingtong Communications has reached the daily limit increase, indicating strong investor interest [1] - Weida Optoelectronics and Doctor Glasses have both risen over 6%, reflecting positive market sentiment [1] Group 2 - Other companies such as Jiahe Intelligent, Thunder Technology, Huilun Crystal, and Mingyue Lenses are also seeing upward trends, suggesting a broader rally in the sector [1]